10 results
424B4
CNTB
Connect Biopharma Holdings Ltd
19 Mar 21
Prospectus supplement with pricing info
4:49pm
protection authorities or data subjects, limitations on retention and secondary use of information, increased requirements pertaining to health data
F-1/A
CNTB
Connect Biopharma Holdings Ltd
18 Mar 21
Registration statement (foreign) (amended)
6:15am
to appropriate data protection authorities or data subjects, limitations on retention and secondary use of information, increased requirements pertaining
F-1/A
EX-10.3
CNTB
Connect Biopharma Holdings Ltd
17 Mar 21
Registration statement (foreign) (amended)
6:38am
preceding sentence shall be limited to the number of Shares which have a Fair Market Value on the date of delivery or retention no greater than … under clause (ii) above by the Company’s retention of Shares from the Award creating the tax obligation and there is a public market for Shares
F-1/A
EX-1.1
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
the Securities Act, including timely filing with the Commission or retention where required and legending and each such free writing prospectus, as of its
F-1/A
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
subjects, limitations on retention and secondary use of information, increased requirements pertaining to health data and pseudonymised (i.e., key
F-1/A
EX-99.1
l8fikkc4s
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-10.3
zulwmamjh4f
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
06jpghrv gu
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
9nj2p41qoythsu4xdu
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
snqxfal w994qfs
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next